CAH vs COR
Cardinal Health Inc. and Cencora, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CAH | COR |
|---|---|---|
| Revenue | $254.2B | $321.3B |
| Net income | $1.7B | $1.6B |
| Gross margin | 3.8% | 3.6% |
| Net margin | 0.7% | 0.5% |
| Return on equity | · | 144.3% |
| Diluted EPS | $7.23 | $7.96 |
| Dividend / share | $2.04 | $2.20 |
| Payout ratio | 28.6% | 28.1% |
| Free cash flow | $4.5B | $3.2B |
| Equity | $-2.9B | $1.5B |
| Net debt / equity | · | 2.19× |
| Current ratio | 0.88× | 0.90× |
| Revenue CAGR 5y | 9.4% | 11.1% |
| Profit CAGR 5y | 22.9% | · |
COR bills 1.3× the revenue of CAH, and CAH keeps more of each dollar of revenue as profit (0.7% against 0.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | CAH | COR |
|---|---|---|
| FY2025 | $254.2B | $321.3B |
| FY2024 | $222.6B | $294.0B |
| FY2023 | $226.8B | $262.2B |
| FY2022 | $205.0B | $238.6B |
| FY2021 | $181.3B | $214.0B |
| FY2020 | $162.5B | $189.9B |
| FY2019 | $152.9B | $179.6B |
| FY2018 | $145.5B | $167.9B |
| FY2017 | $136.8B | $153.1B |
| FY2016 | $130.0B | $146.8B |
Bottom line
| Fiscal year | CAH | COR |
|---|---|---|
| FY2025 | $1.7B | $1.6B |
| FY2024 | $1.6B | $1.5B |
| FY2023 | $852.0M | $1.7B |
| FY2022 | $330.0M | $1.7B |
| FY2021 | $-938.0M | $1.5B |
| FY2020 | $611.0M | $-3.4B |
| FY2019 | $-3.7B | $855.4M |
| FY2018 | $1.4B | $1.7B |
| FY2017 | $256.0M | $364.5M |
| FY2016 | $1.3B | $1.4B |
19 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$67,084,819,000 | COR |
| FY2024 | −$71,380,599,000 | COR |
| FY2023 | −$35,346,411,000 | COR |
| FY2022 | −$33,608,006,000 | COR |
| FY2021 | −$32,662,843,000 | COR |
| FY2020 | −$27,426,926,000 | COR |
| FY2019 | −$26,667,121,000 | COR |
| FY2018 | −$22,405,635,000 | COR |
| FY2017 | −$16,334,826,000 | COR |
| FY2016 | −$16,873,686,000 | COR |
| FY2015 | −$14,415,803,000 | COR |
| FY2014 | −$17,038,127,000 | COR |
| FY2013 | +$3,124,833,000 | CAH |
| FY2012 | +$23,012,194,000 | CAH |
| FY2011 | +$28,856,341,000 | CAH |
| FY2010 | +$24,867,540,000 | CAH |
| FY2009 | +$26,743,010,000 | CAH |
| FY2008 | +$25,801,767,000 | CAH |
| FY2007 | +$21,736,128,000 | CAH |
The higher-revenue side has changed between CAH and COR over this period. The gap has widened since the earliest year compared.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
19 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +0.2 pp | CAH |
| FY2024 | +0.2 pp | CAH |
| FY2023 | −0.3 pp | COR |
| FY2022 | −0.5 pp | COR |
| FY2021 | −1.2 pp | COR |
| FY2020 | +2.2 pp | CAH |
| FY2019 | −2.9 pp | COR |
| FY2018 | −0.0 pp | COR |
| FY2017 | −0.0 pp | COR |
| FY2016 | +0.0 pp | CAH |
| FY2015 | +1.3 pp | CAH |
| FY2014 | +1.0 pp | CAH |
| FY2013 | +0.8 pp | CAH |
| FY2012 | −0.6 pp | COR |
| FY2011 | +0.1 pp | CAH |
| FY2010 | +0.1 pp | CAH |
| FY2009 | −0.0 pp | COR |
| FY2008 | +0.8 pp | CAH |
| FY2007 | +0.8 pp | CAH |
The higher net margin has changed hands between CAH and COR over this period.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CAH's net margin has been more volatile than COR's over the 19 comparable fiscal years — 0.8 percentage points of standard deviation against 0.6.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CAH and COR over these 19 fiscal years — CAH led in 11 and COR in 8.
19 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CAH's return on equity has been more volatile than COR's over the 13 comparable fiscal years — 28.9 percentage points of standard deviation against 27.5.
13 of 15 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between CAH and COR over these 13 fiscal years — CAH led in 5 and COR in 8.
13 of 15 comparable fiscal years — a year missing data on either side is not counted.